Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Other Non Operating Income (2022 - 2025)

CervoMed (CRVO) has disclosed Other Non Operating Income for 7 consecutive years, with $3291.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 20.73% to $3291.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8327.0 through Dec 2025, down 740.26% year-over-year, with the annual reading at -$8327.0 for FY2025, 740.26% down from the prior year.
  • Other Non Operating Income hit $3291.0 in Q4 2025 for CervoMed, up from -$1227.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4.8 million in Q3 2023 to a low of -$620059.0 in Q4 2022.
  • Historically, Other Non Operating Income has averaged $342294.8 across 4 years, with a median of -$191.0 in 2024.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 5429445.45% in 2023 and later crashed 4052.23% in 2025.
  • Year by year, Other Non Operating Income stood at -$620059.0 in 2022, then soared by 99.9% to -$600.0 in 2023, then surged by 554.33% to $2726.0 in 2024, then grew by 20.73% to $3291.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CRVO at $3291.0 in Q4 2025, -$1227.0 in Q3 2025, and -$10256.0 in Q2 2025.